Showing results (1-10 of 1,761) with videos related to

Sort By:
Pageof 177
Pulmonary Circulation|December 9, 2022
Hypoxia-induced pulmonary hypertension upregulates eNOS and TGF-β contributing to sex-linked differences in BMPR2 mutant miceEjehi O Erewele, Maricela Castellon, Omar Loya, et al.
Pulmonary Circulation|July 7, 2022
An unusual case of CTEPH treated by BPA in a patient with a single lung after cancer surgerySzymon Darocha, Paweł Kurzyna, Marta Banaszkiewicz-Cyganik, et al.
Pulmonary Circulation|October 16, 2020
Poor outcome of patients with pulmonary arterial hypertension with insufficient response to phosphodiesterase-5 inhibitors alone or in combination with other specific therapy: a registry-based studyClara Hjalmarsson, Oisin Butler, Roger Hesselstrand, et al.
Pulmonary Circulation|March 28, 2020
Atrial arrhythmias in chronic lung disease-associated pulmonary hypertensionCyrus A Vahdatpour, Jeffrey J Luebbert, Harold I Palevsky
Pulmonary Circulation|March 28, 2020
The filling defect of pulmonary artery, an imaging finding what we should knowMin Liu, Xin Cao Tao, Zhenguo Zhai, et al.
Pulmonary Circulation|September 14, 2020
Pulmonary vessel casting in a rat model of monocrotaline-mediated pulmonary hypertensionZhongkai Zhu, Yifan Wang, Amy Long, et al.
Pulmonary Circulation|December 21, 2020
Reducing rates of readmission and development of an outpatient management plan in pulmonary hypertension: lessons from congestive heart failure managementJustin Dolan, Stacy Mandras, Jinesh P Mehta, et al.
Pulmonary Circulation|May 6, 2022
Prospective clinical assessment of patients with pulmonary arterial hypertension switched from bosentan to macitentan (POTENT)Abdullah M Aldalaan, Sarfraz A Saleemi, Ihab Weheba, et al.
Pulmonary Circulation|May 6, 2022
Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguatFranck F Rahaghi, Vijay P Balasubramanian, Robert C Bourge, et al.
Pulmonary Circulation|May 6, 2022
Critical role for the lung endothelial nonmuscle myosin light-chain kinase isoform in the severity of inflammatory murine lung injuryCarrie L Kempf, Saad Sammani, Tadeo Bermudez, et al.
Pageof 177